These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

986 related articles for article (PubMed ID: 26019458)

  • 1. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
    He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
    World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of distal subtotal gastrectomy with standard D2 and extended D2 lymphadenectomy for locally advanced gastric cancer.
    Zhang CD; Shen MY; Zhang JK; Ning FL; Zhou BS; Dai DQ
    Sci Rep; 2015 Nov; 5():17273. PubMed ID: 26602830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of complication grade on survival following curative gastrectomy for carcinoma.
    Jiang N; Deng JY; Ding XW; Zhang L; Liu HG; Liang YX; Liang H
    World J Gastroenterol; 2014 Jul; 20(25):8244-52. PubMed ID: 25009399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer.
    Lee SE; Lee JH; Ryu KW; Nam B; Kim CG; Park SR; Kook MC; Kim YW
    Hepatogastroenterology; 2012; 59(114):430-5. PubMed ID: 22353511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is endoscopic resection an acceptable treatment for undifferentiated EGC?
    Park J; Choi KD; Kim MY; Lee JH; Song HJ; Lee GH; Jung HY; Kim JH
    Hepatogastroenterology; 2012; 59(114):607-11. PubMed ID: 21940373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of positive transection margins with gastric cancer survival and local recurrence.
    Bickenbach KA; Gonen M; Strong V; Brennan MF; Coit DG
    Ann Surg Oncol; 2013 Aug; 20(8):2663-8. PubMed ID: 23536054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Low Weight Affects Long-term Outcomes Following Curative Gastrectomy for Gastric Cancer.
    Komatsu S; Kosuga T; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    Anticancer Res; 2018 Sep; 38(9):5331-5337. PubMed ID: 30194185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
    Jin LX; Moses LE; Squires MH; Poultsides GA; Votanopoulos K; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Strasberg SM; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine E; Winslow ER; Saunders ND; Spolverato G; Maithel SK; Fields RC
    Ann Surg; 2015 Dec; 262(6):999-1005. PubMed ID: 25607760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.
    Sakar B; Karagol H; Gumus M; Basaran M; Kaytan E; Argon A; Ustuner Z; Bavbek SE; Bugra D; Aykan FN
    Am J Clin Oncol; 2004 Apr; 27(2):205-9. PubMed ID: 15057162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HER-2 Protein is a High-Risk Factor for Patients with Surgically-Resected Stage T3 Gastric Adenocarcinoma.
    Zhang Z; Wang B; Huang G; Wang R; Song J; Lin S; Wang W; Jiang Y; Huang Q; Wang L
    Clin Lab; 2017 Jan; 63(1):115-125. PubMed ID: 28164509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
    Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
    J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.
    Du CY; Chen JG; Zhou Y; Zhao GF; Fu H; Zhou XK; Shi YQ
    World J Gastroenterol; 2012 Jul; 18(27):3610-6. PubMed ID: 22826628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The patterns and timing of recurrence after curative resection for gastric cancer in China.
    Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
    World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery.
    Sun Z; Wang ZN; Xu YY; Zhu GL; Huang BJ; Xu Y; Liu FN; Zhu Z; Xu HM
    Surgery; 2012 Jun; 151(6):871-81. PubMed ID: 22386276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with recurrence within 2 years after curative surgery for gastric adenocarcinoma.
    Chiang CY; Huang KH; Fang WL; Wu CW; Chen JH; Lo SS; Hsieh MC; Shen KH; Li AF; Niu DM; Chiou SH
    World J Surg; 2011 Nov; 35(11):2472-8. PubMed ID: 21879421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.